CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Investors Domain Investor Relations Press releases

11/19/2021

CHEPLAPHARM continues strong Growth

more chevron_right
Investors Domain Investor Relations Press releases

10/13/2021

CHEPLAPHARM signed deal

more chevron_right
Investor Relations Press releases

06/16/2021

CHEPLAPHARM invests in portfolio of anti-infectives

more chevron_right
Investor Relations Press releases

05/04/2021

CHEPLAPHARM continues on the road to success

more chevron_right
Investor Relations Press releases

04/01/2021

Changes of Management Board per April

more chevron_right
Investor Relations Press releases

03/01/2021

Changes of CHEPLAPHARM Management Board per March

more chevron_right
Investor Relations Press releases

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents

more chevron_right
Investor Relations Press releases

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation

more chevron_right
Investors Domain Investor Relations Press releases

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®

more chevron_right
Investors Domain Investor Relations Press releases

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far

more chevron_right
Back to top expand_less